orphan

(redirected from orphan products)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.
Related to orphan products: Orphan Drug Act

orphan

n. a child, particularly a minor, whose two natural parents are dead. In some cases, such as whether a child is eligible for public financial assistance to an orphan, "orphan" can mean a child who has lost one parent.

orphan

noun abandoned child, abandoned infant, bereaved child, castaway, child without parents, foundling, homeless child, orbus, orphaned child, orphaned infant, parentless child, twice-bereaved child, waif, ward

ORPHAN. A minor or infant who has lost both of his or her parents. Sometimes the term is applied to such a person who has lost only one of his or her parents. 3 Mer. 48; 2 Sim. & Stu. 93; Lo & Man. Inst. B. 1, t. 2, c. 1. See Hazzard's Register of Pennsylvania, vol. 14, pages 188, 1 89, for a correspondence between the Hon. Joseph Hopkinson and ex-president J. Q. Adams as to the meaning of the word Orphan, and Rob. 247.

References in periodicals archive ?
The Rare Diseases and Orphan Products Breakthrough Summit is the largest multi-stakeholder event dedicated to rare diseases and the only rare disease conference co-sponsored by the Food and Drug Administration (FDA).
The FDA's Office of Orphan Products Development is dedicated to supporting the development of products that are promising for treatment and diagnoses of diseases that affect less than 200,000 Americans annually.
Seven-year marketing exclusivity to sponsors of approved orphan products.
Timothy Cote, who was appointed Director of the Office of Orphan Products Development in September, told "The Pink Sheet" that one of his top priorities in the coming year will be to persuade policymakers in Washington to increase the funding for grants for clinical development for orphan drugs.
To further encourage orphan drug availability, accompanying market-oriented incentives for orphan drug development were issued by the Office of Orphan Products Development, under the auspices of FDA (11).
They oppose the initiatives by Senators Kennedy and Hatch to amend the law, because companies might be deprived of the fruits of their large investments in orphan product R & D.
The FDA awards the grants through the Orphan Products Grants Program to encourage clinical development of drugs, biologics, medical devices, or medical foods for use in rare diseases.
Food and Drug Administration's Office of Orphan Products Development has granted orphan designation for AMIGAL in the United States, and the European Commission has designated AMIGAL as an orphan medicinal product in the European Union.
as the new director of the Office of Orphan Products Development.
The ODA provided 7 years of market exclusivity and expanded tax credits for companies developing and marketing orphan drugs, established an Office of Orphan Product Development at the Food and Drug Administration (FDA), and created the Orphan Products Grant Program.
Orphan products are developed to treat rare diseases, or conditions that affect fewer than 200,000 people in the US.